Łukasz Janczewski

10PUBLICATIONS
34CO-AUTHORS
Biologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPowder and particle technologyCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 26, 2026
Design, Synthesis, and Biological Activity of Isothiocyanate-Triazine Conjugates as AChE and BACE1 Inhibitors.

|Jul 20, 2026
Bis-(di-4-phenyl-benzylaminethiocarbonyl)disulfide sensitizes ABCC2/ALDH3A1 overexpressing NSCLC cells to cisplatin.

|Jan 30, 2026
Structures, characteristics, and anticancer mechanisms of taxanes, beta-glucans, and isothiocyanates.

Piotr Gromek, Weronika Kruczkowska, Kacper Górecki

|Oct 28, 2023
Synthesis and Characterization of Antibacterial Chitosan Films with Ciprofloxacin in Acidic Conditions.

Dominik Sikorski, Piotr Rosiak, Łukasz Janczewski

|Sep 28, 2023
Isothiocyanates as Tubulin Polymerization Inhibitors-Synthesis and Structure-Activity Relationship Studies.

Renata Grzywa, Mateusz Psurski, Anna Gajda

|Aug 12, 2022
Isothiocyanates (ITCs) 1-(Isothiocyanatomethyl)-4-phenylbenzene and 1-Isothiocyanato-3,5-bis(trifluoromethyl)benzene-Aldehyde Dehydrogenase (ALDH) Inhibitors, Decreases Cisplatin Tolerance and Migratory Ability of NSCLC.

Jolanta Kryczka, Jakub Kryczka, Łukasz Janczewski

Pageof 2

Frequent Collaborators

6 joint publications

Beata Kolesińska

2 joint publications

Dorota Kręgiel

2 joint publications

Kacper Górecki

2 joint publications

Renata Grzywa